Faster, smarter, and automated cell analysis for labs, hospitals, and research teams. Our AI-powered flow cytometry software reduces time, eliminates errors, and enhances diagnostic confidence.
FlowView helps laboratories analyze flow cytometry data more quickly and consistently. The platform uses a deterministic model that produces consistent results every time, regardless of the operator.
It turns high-dimensional files into clear visuals and identifies abnormal cells in minutes. Clinicians and researchers can access their data easily without lengthy manual workflows or operator-dependent gating.
FlowView helps laboratories analyze flow cytometry data more quickly and consistently. The platform uses a deterministic model that produces consistent results every time, regardless of the operator.
It turns high-dimensional files into clear visuals and identifies abnormal cells in minutes. Clinicians and researchers can access their data easily without lengthy manual workflows or operator-dependent gating.
Flow cytometry files are high-dimensional and dense. Interpreting them by hand is slow and inconsistent, especially when panels differ across sites or instruments.
Manual gating can take hours, and the results can vary depending on the operator. Small changes in gating decisions can lead to different outcomes, which is problematic in clinical work where reproducibility is important.
Larger datasets slow down laboratories. Traditional analysis methods either require downsampling or involve long processing times, and many tools struggle when event counts spike.
Read the full article about our approach.
Challenge | Our Solution |
|---|---|
Slow analysis
| Results in minutes, even for MRD or multi-tube cases. |
High expertise required | Simplified visuals readable by clinicians and non-specialists. |
Operator variability | Deterministic output improves reproducibility and auditability. |
Risk of missing rare events
| Manual gating risks excluding rare populations. ECLIPSE was designed to detect low-frequency abnormal cells, including MRD down to 0.001%.
|
Large datasets
| Handles millions of events without downsampling. |
Read our white paper for more details.
ECLIPSE filters out normal cells, displaying only abnormal populations. This makes complex samples clearer and reduces interpretation errors.
Most samples are processed in minutes, even when the files contain millions of events. This reduces turnaround time and eliminates bottlenecks in routine and urgent workflows.
The platform can handle large, high-dimensional datasets without downsampling. This gives researchers clean, reproducible results for advanced studies.
Deterministic output provides consistent and auditable results, supporting better clinical decisions and patient care across users and instruments.
FlowView Diagnostics is a pioneering company and your go-to partner in AI-powered flow cytometry solutions. We are on a mission to change how complex flow cytometry data is analyzed, making it smarter, faster, and more actionable for healthcare professionals, researchers, and Clinical Research Organizations (CROs).
With tools like our Asudes platform, we help you find patterns, streamline workflows, and focus on what truly matters, and that is improving patient outcomes.
Asudes is a cloud-based SaaS (Software as a Service) platform built for modern flow cytometry. Using advanced AI algorithms, it processes massive datasets and simplifies them into clear, visual insights that anyone can understand.
Say goodbye to manual analysis. Asudes eliminates noise, highlights abnormalities, and empowers faster, more accurate decisions. Designed with an intuitive interface, it is perfect for labs, hospitals, and research teams that want to focus less on data crunching and more on discoveries.
Our AI-powered methodology provides automated flow cytometric identification of disease-specific cells by the patented Eclipse algorithm.
Our platform also compares data to your own control groups and delivers a thorough analysis. Paired with our intuitive interface, this offers a more advanced yet user-friendly solution.
Our innovation automatically detects disease-specific cells and compares them against control groups for unmatched accuracy and reproducibility.
Unlike traditional methods, Eclipse saves time, reduces human error, and delivers consistent results every single time.
Do you have any questions? Contact us →
You may unsubscribe anytime. View our privacy policy for more information.